reviews on glp-1 receptor agonists effective for obesity and liver disease treatment GLP-1 Medications: Everything You Need
Description
As the first marketed dual GCG/GLP-1 receptor agonist , mazdutide has been recommended by multiple clinical guidelines in China and expert consensus on obesity management on account of its innovative mechanism and solid evidence base
Front Endocrinol (Lausanne) 14:1240263 Sattar N, Neeland IJ, Dahlqvist Leinhard O, Fernandez Lando L, Bray R, Linge J et al (2025) Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial
India faces the double burden of obesity and non-communicable diseases, being the diabetes capital
His diabetes was easier to manage, too, as his pancreas wasnt working in overdrive to clear excess blood sugar
